产品编号：M262297
产品规格：25mg
产品价格：面议
| 标准品编号: | M262297 |
| 名称: | 10α-Methoxy-1-methyl-d3-9,10-dihydrolysergol |
| 别名: | Indolo[4,3-fg]quinoline Ergoline-8-methanol Deriv.-d3; (+)-(5R,10S)-Meluol-d3; 1,6-Dimethyl-8β-(hydroxymethyl)-10α-methoxyergoline-d3; 1-Methyl-d3-10α-methoxydihydrolysergol; 10-Methoxy-1,6-dimethylergoline-8β-methanol-d3; 1-Methyl-d3-10α-Methoxy-9,10-dihydrolysergol; ; 10α-Methoxy-1-methyl-d3-dihydrolysergol; O10,1-Dimethyllumilysergol-d3; MMDL-d3 |
| 参考CAS号: | Unlabelled: 35155-28-3 |
| 分子式: | C₁₈H₂₁D₃N₂O₂ |
| 外观: | 白色至淡黄色固体 |
| 熔点: | >149°C (dec.) |
| 分子量: | 303.41 |
| 储存: | 冰箱 |
| 溶解度: | DMSO (Slightly), Methanol (Slightly) |
| 种类: | Research Tools; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Lysergic Acid Derivatives; Tryptamines; |
| 应用: | α-Methoxy-1-methyl-d3-9,10-dihydrolysergol is the labeled analogue of 10α-Methoxy-1-methyl-9,10-dihydrolysergol (M262295), a nicergoline (N394550) metabolite that has been shown to have antioxidant activity, preventing glutathione (GSH) depletion and lipid peroxidation; thus it has shown potential as treatment of neuroleptic-induced side effects. |
| 参考文献 | |
